Showing results (401-410 of 6,497) with videos related to

Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|November 2, 2018
The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic reviewMichelle L Giles, Sushena Krishnaswamy, Kristine Macartney, et al.
Human Vaccines & Immunotherapeutics|November 7, 2018
Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adultsJoon Young Song, Jacob Lee, Heung Jeong Woo, et al.
Human Vaccines & Immunotherapeutics|November 16, 2016
Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexationGrace Cole, Joanne McCaffrey, Ahlam A Ali, et al.
Human Vaccines & Immunotherapeutics|November 19, 2016
Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccinesEdward W Thommes, Morgan Kruse, Michele Kohli, et al.
Human Vaccines & Immunotherapeutics|October 22, 2016
The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis modelAshleigh A McGirr, Kevin L Schwartz, Upton Allen, et al.
Human Vaccines & Immunotherapeutics|October 22, 2016
Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014Xin Yao, Lian-Lian Bian, Wei-Wei Lu, et al.
Human Vaccines & Immunotherapeutics|October 21, 2016
Ebola vaccines in clinical trial: The promising candidatesYuxiao Wang, Jingxin Li, Yuemei Hu, et al.
Human Vaccines & Immunotherapeutics|November 22, 2016
Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole bloodRebecca A Erwin-Cohen, Aimee I Porter, Phillip R Pittman, et al.
Human Vaccines & Immunotherapeutics|December 8, 2016
The "Fluad Case" in Italy: Could it have been dealt differently?Miriam Levi, Ersilia Sinisgalli, Chiara Lorini, et al.
Human Vaccines & Immunotherapeutics|December 8, 2016
A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaksGeorgi Shukarev, Benoit Callendret, Kerstin Luhn, et al.
Pageof 650